← All organizations
Highest phase reached
Phase 3
First clinical trial
Dec 2, 2022Last known activity
Jun 7, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (11 distinct, 6 trials)
Phase 3 (4 own, 0 via acquisition)
Other trials (5 own, 0 via acquisition)
Recent trials (15)
- NCT06813118Lead sponsorPhase 1Jun 7, 2024
- NCT06813118Sponsor investigatorPhase 1Jun 7, 2024
- NCT06813118OfficialPhase 1Jun 7, 2024
- NCT07123792Lead sponsorN/AJun 3, 2024
- NCT07123792OfficialN/AJun 3, 2024
- NCT07125911Sponsor investigatorN/AApr 7, 2024
- NCT07125911OfficialN/AApr 7, 2024
- NCT07125911Lead sponsorN/AApr 7, 2024
- NCT06141330Reponsible party - principal investigatorN/ADec 1, 2023
- NCT06141330Lead sponsorN/ADec 1, 2023
- NCT07146997Sponsor investigatorPhase 3Nov 23, 2023
- NCT07146997Lead sponsorPhase 3Nov 23, 2023
- NCT07146997CollaboratorPhase 3Nov 23, 2023
- NCT06220344Lead sponsorPhase 2/Phase 3Dec 2, 2022
- NCT06220344Sponsor investigatorPhase 2/Phase 3Dec 2, 2022
Details
- Last known activity
- Jun 7, 2024